Published in Dig Dis Sci on March 18, 2011
The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients. Int J Med Sci (2013) 0.99
Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86
Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis. Dig Dis Sci (2016) 0.75
Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis. J Gastroenterol (2016) 0.75
Management of hepatocellular carcinoma. Hepatology (2005) 27.42
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet (2002) 12.16
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology (2003) 11.55
Rifaximin treatment in hepatic encephalopathy. N Engl J Med (2010) 9.60
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology (2010) 8.11
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89
Liver fibrosis -- from bench to bedside. J Hepatol (2003) 5.80
Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol (2007) 5.77
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med (2000) 4.67
Projecting future complications of chronic hepatitis C in the United States. Liver Transpl (2003) 3.84
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol (2000) 3.43
National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 (2007) 3.40
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion (1985) 3.35
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood (2002) 3.18
The burden of hepatitis C in the United States. Hepatology (2002) 3.16
The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11
Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med (2006) 3.11
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology (2010) 3.00
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology (2002) 2.93
HLA class II antibodies in transfusion-related acute lung injury. Transfusion (2001) 2.93
AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology (2005) 2.90
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology (2002) 2.90
Chemoembolization for hepatocellular carcinoma. Gastroenterology (2004) 2.89
Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol (2009) 2.79
Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol (2002) 2.70
Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med (2000) 2.67
Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet (1966) 2.65
Treatment of hepatic encephalopathy. N Engl J Med (1997) 2.60
SPONTANEOUS PERITONITIS AND BACTEREMIA IN LAENNEC'S CIRRHOSIS CAUSED BY ENTERIC ORGANISMS. A RELATIVELY COMMON BUT RARELY RECOGNIZED SYNDROME. Ann Intern Med (1964) 2.54
Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37
Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology (2010) 2.30
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology (1994) 2.27
TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut (2010) 2.24
Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med (2002) 2.23
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med (1995) 2.21
Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg (2004) 2.20
Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis (1999) 2.15
Deaths: final data for 2002. Natl Vital Stat Rep (2004) 2.14
Improving prognosis following a first variceal haemorrhage over four decades. Gut (2001) 2.14
The evaluation of renal function and disease in patients with cirrhosis. J Hepatol (2010) 2.10
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology (1977) 2.10
Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2008) 2.08
Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion (1992) 2.07
Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol (2006) 1.90
Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life". JAMA (2006) 1.80
Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology (2004) 1.71
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology (2008) 1.70
Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int (2007) 1.66
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology (2003) 1.66
Coagulation disorders in liver disease. Semin Liver Dis (2002) 1.66
Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology (1994) 1.64
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology (2003) 1.64
Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med (1999) 1.63
Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology (1990) 1.60
Nutrition and survival in patients with liver cirrhosis. Nutrition (2001) 1.60
Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients. Clin Infect Dis (1998) 1.55
Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology (2008) 1.51
INFECTION OF ASCITIC FLUID IN PATIENTS WITH HEPATIC CIRRHOSIS. Gut (1963) 1.50
Under-diagnosis of common chronic diseases: prevalence and impact on human health. Int J Clin Pract (2007) 1.48
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis (1978) 1.47
Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology (1988) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol (2001) 1.37
The epidemiology of acute and chronic hepatitis C. Clin Liver Dis (1997) 1.36
Spontaneous bacterial peritonitis. Dis Mon (1985) 1.30
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Sertraline as a first-line treatment for cholestatic pruritus. Hepatology (2007) 1.24
Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc (2010) 1.24
Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology (1996) 1.23
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation (1994) 1.18
Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc (2009) 1.16
Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr (1996) 1.16
Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl (2002) 1.14
Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol (2002) 1.11
The therapeutic use of acetaminophen in patients with liver disease. Am J Ther (2005) 1.09
The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis (2010) 1.07
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology (2001) 1.04
Nutritional assessment in various stages of liver cirrhosis. Nutrition (2001) 1.04
Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology (1992) 1.03
Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl (2000) 1.02
Spontaneous bacterial peritonitis: a historical perspective. J Hepatol (2004) 1.02
Hepatic hydrothorax. Curr Opin Pulm Med (2003) 1.02
Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation (2005) 0.98
Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol (2003) 0.98
Decreasing in-hospital mortality for oesophageal variceal hemorrhage in the USA. Eur J Gastroenterol Hepatol (2008) 0.95
Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest (2004) 0.94
A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int (1997) 0.94
Pathogenesis and treatment of pruritus in cholestasis. Drugs (2008) 0.93
Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci (2006) 0.92
Arachidonic acid derivatives and renal function in liver cirrhosis. Semin Nephrol (1997) 0.92
Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World J Gastroenterol (2009) 0.91
Hepatic hydrothorax. Curr Opin Pulm Med (1998) 0.89
Vibrio vulnificus infection: an important cause of septicemia in patients with cirrhosis. South Med J (1997) 0.88
Transjugular intrahepatic portosystemic shunt: angiographic follow-up and secondary interventions. Radiology (1994) 0.88
Neomycin reduces the intestinal production of ammonia from glutamine. Adv Exp Med Biol (1994) 0.83
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol (2015) 1.99
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68
Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant (2003) 1.60
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol (2002) 0.95
Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest (2004) 0.94
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl (2006) 0.90
Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl (2009) 0.90
Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. J Oral Maxillofac Surg (2010) 0.88
Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl (2014) 0.87
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol (2011) 0.87
Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl (2006) 0.87
Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant (2012) 0.84
Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci (2013) 0.84
Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation (2005) 0.83
Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery (2013) 0.83
Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease. J Crohns Colitis (2012) 0.83
Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. J Hepatol (2011) 0.82
Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl (2005) 0.82
Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol (2007) 0.82
Results of retransplantation for recurrent hepatitis C. Hepatology (2003) 0.82
Overdose with suicidal intent: ethical considerations for liver transplant programs. Liver Transpl (2011) 0.82
Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation (2015) 0.82
Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol (2012) 0.81
Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assays. Am J Transplant (2004) 0.81
Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation (2007) 0.79
Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease. Hepatol Int (2010) 0.78
Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods (2010) 0.78
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78
Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl (2007) 0.78
Adult live donor liver transplantation. Clin Liver Dis (2005) 0.78
Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. AJR Am J Roentgenol (2015) 0.77
Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology (2002) 0.77
Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation. J Gastrointest Surg (2009) 0.77
Treating chronic hepatitis C in the primary care setting. Semin Liver Dis (2005) 0.77
Acute cellular rejection resulting in sinusoidal obstruction syndrome and ascites postliver transplantation. Transplantation (2011) 0.77
Long-term care of the liver transplant recipient. Clin Liver Dis (2007) 0.76
Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy. Liver Transpl (2005) 0.76
Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients. Liver Transpl (2004) 0.76
Domino liver transplantation: a practical option in the face of the organ shortage. Prog Transplant (2003) 0.76
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency. Am J Surg Pathol (2016) 0.75
A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome. Gastroenterol Hepatol (N Y) (2010) 0.75
Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation. Liver Transpl (2007) 0.75
Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study. Liver Transpl (2013) 0.75
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. Scand J Gastroenterol (2013) 0.75
Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res (2009) 0.75
To B(iopsy) or not to B(iopsy) …. Clin Gastroenterol Hepatol (2010) 0.75
Still disease and the liver-an underappreciated association. Gastroenterol Hepatol (N Y) (2011) 0.75
Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol (2008) 0.75
Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors. Pancreas (2011) 0.75
Recurrent hepatitis C virus infection and outcome after living-donor liver transplant. Exp Clin Transplant (2013) 0.75
Therapeutic management of recurrent hepatitis C after liver transplantation. Liver Int (2007) 0.75
Exacerbation of sickle cell disease itself as a cause of abnormal liver chemistry tests. Dig Dis Sci (2006) 0.75
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci (2013) 0.75
Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series. Liver Transpl (2009) 0.75
A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis. Virchows Arch (2014) 0.75
Long-term outcome after liver transplantation. Mt Sinai J Med (2012) 0.75
Curricular guidelines for training in transplant hepatology. Liver Transpl (2002) 0.75
Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis. Arch Pathol Lab Med (2013) 0.75
Endoscopic diagnosis of bleeding Meckel's diverticulum in a multivisceral transplant recipient. Am J Transplant (2003) 0.75
An association of myeloproliferative neoplasms and obliterative portal venopathy. Dig Dis Sci (2014) 0.75
Waitlisted Candidates With Polycystic Liver Disease are More Likely to be Transplanted Than Those With Chronic Liver Failure. Transplantation (2017) 0.75
Excellent results of cardiac surgery in patients with previous liver transplantation. Liver Transpl (2007) 0.75
Lactulose: how many ways can one drug be prescribed? Am J Gastroenterol (2011) 0.75
Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation. Expert Rev Clin Immunol (2007) 0.75